Get the Stockscreener App
87.49
0.39%
-0.46
Globus Medical Inc stock is traded at $87.49, with a volume of 597.73K.
It is down -0.39% in the last 24 hours and up +4.98% over the past month.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
See More
Previous Close:
$87.95
Open:
$88.3
24h Volume:
597.73K
Relative Volume:
0.55
Market Cap:
$11.98B
Revenue:
$2.48B
Net Income/Loss:
$91.51M
P/E Ratio:
130.58
EPS:
0.67
Net Cash Flow:
$293.77M
1W Performance:
-5.51%
1M Performance:
+4.98%
6M Performance:
+24.21%
1Y Performance:
+65.80%
1-Day Range:
$87.47
$89.39
1-Week Range:
$84.00
$93.92
52-Week Range:
$49.33
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Name
Globus Medical Inc
Sector
Industry
Phone
610-930-1800
Address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
87.47 | 11.98B | 2.48B | 91.51M | 293.77M | 0.67 |
|
ABT
Abbott Laboratories
|
129.06 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.61 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
392.90 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.01 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.06 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-07-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| May-20-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-18-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-19-23 | Upgrade | Stifel | Hold → Buy |
| Mar-30-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-10-23 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-10-23 | Downgrade | Loop Capital | Buy → Hold |
| Feb-10-23 | Downgrade | Needham | Buy → Hold |
| Feb-10-23 | Downgrade | Truist | Buy → Hold |
| Feb-10-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-28-22 | Initiated | Wells Fargo | Overweight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-13-21 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-29-21 | Initiated | Loop Capital | Buy |
| Feb-18-21 | Resumed | Needham | Buy |
| Dec-08-20 | Initiated | Citigroup | Buy |
| Oct-20-20 | Initiated | Stifel | Hold |
| Aug-06-20 | Reiterated | Needham | Buy |
| Aug-06-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jul-21-20 | Initiated | Northland Capital | Market Perform |
| Jul-06-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-08-20 | Reiterated | Needham | Buy |
| Mar-18-20 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-12-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Aug-02-19 | Reiterated | Needham | Buy |
| May-24-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| May-03-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Upgrade | UBS | Neutral → Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-27-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-01-18 | Initiated | Cantor Fitzgerald | Overweight |
| May-03-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Upgrade | Needham | Hold → Buy |
View All
Globus Medical Inc Stock (GMED) Latest News
Globus Medical to acquire Nevro for $5.85 per share - Yahoo Finance
Globus Medical to Acquire Nevro Corp. in Strategic $250 Million Deal - MyChesCo
Needham maintains hold on Globus Medical stock post-acquisition - MSN
Jefferies maintains Buy on Globus Medical, target at $105 - MSN
Globus Medical buying chronic pain company Nevro for $250M - BioWorld Online
BTIG maintains $91 target on Globus Medical stock post-acquisition - MSN
Globus Medical Announces Acquisition of Nevro Corp - TipRanks
Globus to buy Nevro for $250M - MedTech Dive
Stifel maintains GMED buy rating, $92 target amid NVRO buyout - MSN
Nevro Corp Announces Merger Agreement with Globus Medical - TipRanks
Globus Medical Buys Device Maker Nevro In $250M Deal - Law360
Globus Medical to acquire Nevro for $250 million - MSN
Globus Medical to Acquire Nevro in $250 Million Deal to Expand Chronic Pain Treatment Portfolio - Yahoo Finance
Globus Medical to buy California life sciences firm for $250M - The Business Journals
Globus Medical reaffirms FY25 stand-alone EPS $3.40-$3.50, consensus $3.47 - MSN
Analyst Expectations For Globus Medical's Future - Benzinga
Globus acquisition of Nevro ‘fairly low-risk bet,’ says BTIG - TipRanks
BTIG maintains $91 target on Globus Medical stock post-acquisition By Investing.com - Investing.com UK
GMEDGLOBUS MEDICAL INC Latest Stock News & Market Updates - StockTitan
Globus Medical to buy Nevro in $250M all-cash deal (GMED:NYSE) - Seeking Alpha
Globus Medical to Acquire Nevro -February 06, 2025 at 09:58 am EST - Marketscreener.com
Globus Medical to acquire Nevro for $250 million By Investing.com - Investing.com UK
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients - GlobeNewswire
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients - Benzinga
Major Medical Device Acquisition: Globus Medical Takes Over Nevro in Strategic $250M Pain Tech Deal - StockTitan
Strategic Board Shake-up: Dentsply Sirona Taps Innovation Expert and Healthcare CEO - StockTitan
Globus Medical, Inc. entered into a definitive agreement to acquire Nevro Corp. for approximately $250 million. - Marketscreener.com
BlackRock, Inc. Expands Stake in Globus Medical Inc. - GuruFocus.com
Globus Medical (GMED) is a Top-Ranked Growth Stock: Should You Buy? - MSN
Top 2 Health Care Stocks That May Crash In February - Benzinga
Global PEEK Interbody Devices Market is expected to reach US$ 4.6 - openPR
Swedbank AB Has $39.33 Million Stake in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Boston Trust Walden Corp Has $51.25 Million Stock Holdings in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Precision Wealth Strategies LLC Invests $479,000 in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical (NYSE:GMED) Hits New 12-Month HighShould You Buy? - MarketBeat
Globus Medical to Announce Q4 and Full-Year 2024 Financial Results - MSN
Globus Medical FY2024 EPS Forecast Lowered by Roth Capital - MarketBeat
Globus Medical (NYSE:GMED) Upgraded to "Buy" at StockNews.com - MarketBeat
Subdued Growth No Barrier To Globus Medical, Inc.'s (NYSE:GMED) Price - Simply Wall St
Globus Medical stock soars to all-time high of $93.68 - MSN
Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call - GlobeNewswire
Globus Medical stock soars to all-time high of $93.68 By Investing.com - Investing.com Canada
Robotic-assisted Surgery Systems Market Detailed In New - openPR
UMB Bank n.a. Has $45,000 Stock Holdings in Globus Medical, Inc. (NYSE:GMED) - Defense World
Globus Medical Surges 62.1% in a Year: What's Driving the Stock? - MSN
Exchange Traded Concepts LLC Sells 26,891 Shares of Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Encompass More Asset Management Invests $545,000 in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
FY2025 EPS Estimates for Globus Medical Lifted by Analyst - Defense World
HB Wealth Management LLC Invests $301,000 in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Zacks Research Lifts Earnings Estimates for Globus Medical - MarketBeat
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Globus Medical Inc Stock (GMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.21%
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):